FDA Drug Recalls

Recalls / Class II

Class IID-0764-2023

Product

Nafcillin for Injection, USP, 10 gram per Pharmacy Bulk Package, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-141-99

Affected lot / code info
Lot: NFT101, EXP: 5/31/2024; Lots: NFT201, NFT202, EXP: 2/28/2025; Lots: NFT203, NFT204, EXP: 5/31/2025

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Sagent Pharmaceuticals Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1901 N Roselle Rd Ste 450, N/A, Schaumburg, Illinois 60195-3194

Distribution

Quantity
370,200 bottles
Distribution pattern
Nationwide USA

Timeline

Recall initiated
2023-05-19
FDA classified
2023-05-23
Posted by FDA
2023-05-31
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0764-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls